BDBM395267 1-Fluoro-N-4-[[(4aR,5aR) or (4aS,5aS)]-5a-methyl-4-oxo-3-(phenylamino)-1,4,4a,5,5a,6-hexahydrocyclopropa[f]indol-2-yl]pyridin-2-ylcyclopropanecarboxamide::US10308629, Example 31

SMILES C[C@@]12Cc3[nH]c(-c4ccnc(NC(=O)C5(F)CC5)c4)c(Nc4ccccc4)c3C(=O)[C@@H]1C2

InChI Key InChIKey=UREFADXVYIDPLS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 395267   

TargetMitotic checkpoint serine/threonine-protein kinase BUB1(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 395267BDBM395267(US10308629, Example 31 | 1-Fluoro-N-4-[[(4aR,5aR) ...)
Affinity DataIC50: 52nMAssay Description:Bub1-inhibitory activities of compounds described in the present invention were quantified using a time-resolved fluorescence energy transfer (TR-FRE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent